-
cds.ahrq.gov/taxonomy/term/32741
August 23, 2024 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - the purposes of this artifact, CVD is represented by a grouped value set that represents an array of conditions … Per the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - requested CDS to identify those at risk for developing CVD who also have a history of
other comorbid conditions … technology company uses the logic in this artifact, expanding its structured representation
of the comorbid conditions … Inclusions “Hypertension” Defined as essential (primary) and nonessential (secondary) hypertension
conditions … is represented as multiple value
sets published on the Value Set Authority Center to express CVD “conditions … Exclusions “breastfeeding” Diagnosis of breastfeeding (which includes conditions associated with
lactation
-
cds.ahrq.gov/taxonomy/term/23041
September 16, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - Under idealized conditions, preliminary CQL code may be generated quickly, but this does not include … artifact, CVD is defined by the value set created by QIP to represent ASCVD, as evidenced by the following conditions … are not at increased risk for bleeding"
The USPSTF full recommendation statement lists the following conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - Under idealized conditions, preliminary CQL
code may be generated quickly, but this does not include … bleeding”
The USPSTF full recommendation statements (2016 and 2022 together) named the following conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - These links
address prediabetes, type 2 diabetes, and the health risk from those conditions. Ms. … company uses the logic in this artifact and
adds additional structured representation of comorbid conditions … to identify those at risk for developing diabetes who also have a
8
history of other comorbid conditions … • Exclusion of conditions or observations representing known elevated blood glucose
levels: The intent … It excludes type 1 and type 2 DM, steroid-
induced DM, and codes representing conditions occurring in
-
cds.ahrq.gov/sites/default/files/cds/artifact/66551/ASPIRE_GuidanceForOsteoporosisFlow.pdf
July 18, 2023 - Guidance for Osteoporosis
Patient 65+
Patient is not qualified
for recommendation
No
Patient has
fall risk condition
Yes
No
General Info on Bisphosphonate
Handout
Yes
Patient has active
Bisphosphonate
treatment
active Bisphosphonate
treatment < 5 years
Yes
active Bisphosphonate
treatment > 5 years…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - These links
address prediabetes, type 2 diabetes, and the health risk from those conditions. Ms. … company uses the logic in this artifact and
adds additional structured representation of comorbid conditions … that are risk factors for developing prediabetes or diabetes, and having
a history of CVD comorbid conditions … the Patient Population Under
Consideration, the recommendation indicates that persons with specific conditions … It excludes type 1 and type 2 DM, steroid-
induced DM, and codes representing conditions occurring in
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
January 01, 2024 - represented using multiple value sets published on the Value
Set Authority Center to express ASCVD “conditions … Cholesterol Management Work Group’s recommendations, only “active” cases of
rhabdomyolysis and the conditions … benefit versus harm of initiating a statin must be closely considered for patients with the listed
conditions … whether to include
active/relapsed hepatitis A and B in the exclusions or express all liver-related conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - Under idealized conditions, preliminary CQL code may be generated quickly, but this does not include … purposes of this artifact, ASCVD is represented by a grouped value set that represents an array of conditions … treated for hypertension, since some anti-hypertensive medications can be prescribed for other medical conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Under idealized conditions, preliminary CQL code may be generated quickly, but this does not include … purposes of this artifact, ASCVD is represented by a grouped value set that represents an array of conditions … treated for hypertension, since some anti-hypertensive medications can be prescribed for other medical conditions
-
cds.ahrq.gov/taxonomy/term/45981
February 26, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Summary_July_2021.pdf
January 01, 2021 - July 2021 CDS Connect Work Group Meeting Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
July 15, 2021
3:00 – 4:30 pm ET
Attendees: 45 people, including 7 phone dial-ins
Organization Attendees
AHRQ Sponsors Rowland Gamache, Edwin Lomotan, Mary Nix, Steve Bernstein, Mari…
-
cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Presentation.pdf
January 01, 2021 - October 2021 CDS Connect Work Group Call
October 2021 CDS Connect Work Group Call
Agenda
Schedule Topic
3:00 - 3:02 Roll Call, Michelle Lenox (MITRE)
3:02 - 3:05 Review of the Agenda, Maria Michaels (CDC)
3:05 - 3:50 Share and Discuss CDS Connect Priorities through September 2022,
Lacy Fabian (MITRE)
3:50 - …
-
cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
January 01, 2024 - CDS Connect: Final Report 2024
CDS Connect: Final Report 2024
CDS Connect
Clinical Decision Support (CDS) Connect is a freely available, web-based platform that enable…
-
cds.ahrq.gov/sites/default/files/workgroups/38971/CDS_Connect_WG_December_2021_Summary.pdf
January 01, 2021 - with his efforts to involve patients in CDS
related to chronic pain, especially for musculoskeletal conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
October 01, 2017 - an Exclusion
Per the Cholesterol Management Work Group, only ACTIVE cases of Rhabdomyolysis and the conditions … benefit versus harm of initiating a statin must be closely considered for patients with the listed conditions … whether to include Active/Relapsed Hepatitis A and B in the exclusions or express all liver-related conditions
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2023.pdf
January 01, 2023 - CDS Connect: Final Report 2023
CDS Connect: Final Report 2023
CDS Connect
Clinical Decision Support (CDS) Connect is a freely available, web-based platform that enables …
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…